Note 11 – Equity-Based Compensation

With each stock grant, the Company awards each of its three independent directors an equal number of restricted shares. The table below summarizes total stock grants as of December 31, 2025 with a vesting date after January 1, 2023.

 

Grant Date

Class of common stock granted

Total number of shares granted

 

Grant Date Fair Value Per Share

 

Total Fair Value of Grant

 

Proportion of total shares that vest annually

 

Vesting Date Year 1

Vesting Date Year 2

Vesting Date Year 3

December 1, 2020

Class I

 

1,393

 

$

21.54

 

$

30

 

 

1/3

 

12/1/2021

12/1/2022

12/1/2023

October 14, 2021

Class I

 

1,477

 

$

20.31

 

$

30

 

 

1/3

 

10/14/2022

10/14/2023

10/14/2024

October 3, 2022

Class I

 

1,534

 

$

19.55

 

$

30

 

 

1/3

 

10/3/2023

10/3/2024

10/3/2025

September 29, 2023

Class I

 

1,722

 

$

17.42

 

$

30

 

 

1/3

 

9/29/2024

9/29/2025

9/29/2026

September 12, 2024

Class I

 

1,812

 

$

16.56

 

$

30

 

 

1/3

 

9/12/2025

9/12/2026

9/12/2027

September 18, 2025

Class I

 

1,871

 

$

16.03

 

$

30

 

 

1/3

 

9/18/2026

9/18/2027

9/18/2028

Under the RSP, restricted shares generally vest over a three-year vesting period from the date of the grant, subject to the specific terms of the grant. Restricted shares are included in common stock outstanding on the grant date. The grant-date value of the restricted shares is amortized over the vesting period representing the requisite service period. Compensation expense associated with the restricted shares issued to the independent directors was $30, $30 and $31 for the years ended December 31, 2025, 2024 and 2023, respectively. As of December 31, 2025, the Company had $53 of unrecognized compensation expense related to the unvested restricted shares, in the

aggregate. The weighted average remaining period that compensation expense related to unvested restricted shares will be recognized is 1.4 years. The total fair value at the vesting date for restricted shares that vested during the year ended December 31, 2025 was $27.

A summary table of the status of the restricted shares granted under the RSP is presented below:

 

 

 

Restricted Shares

 

 

Weighted
Average
Grant Date
Fair Value Per Share

 

Outstanding at December 31, 2024

 

 

3,471

 

 

$

17.29

 

Granted

 

 

1,871

 

 

 

16.03

 

Vested

 

 

1,689

 

 

 

17.76

 

Converted

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Outstanding at December 31, 2025

 

 

3,653

 

 

$

16.42

 

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.